SCHEMBL7329614

SCHEMBL7329614

Cc1cc(-c2ccccc2)n(C)c1C=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.44
ALDH1A1 P00352 4/20 0.44
HPGD P15428 2/20 0.44
BRD4 O60885 1/20 0.42
CCNB2 O95067 1/20 0.40
CDK1 P06493 1/20 0.40
CCNB1 P14635 1/20 0.40
CDK5 Q00535 1/20 0.40
CDK5R1 Q15078 1/20 0.40
CCNB3 Q8WWL7 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.39
LMNA P02545 1/20 0.39
CYP19A1 P11511 1/20 0.38
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
KDM4E B2RXH2 2/20 0.37
NPSR1 Q6W5P4 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
CASP3 P42574 1/20 0.37
SENP8 Q96LD8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8989151 0.75 KMT2A (0.44) KMT2AALDH1A1HPGDBRD4CCNB2
SCHEMBL28630613 0.75 KMT2A (0.52) KMT2AALDH1A1HPGDBRD4CCNB2
SCHEMBL7688700 0.71 ALDH1A1 (0.45) KMT2AALDH1A1HPGDBRD4CCNB2
SCHEMBL10972522 0.70 ALDH1A1 (0.34) ALDH1A1SMN1; SMN2LMNAKDM4EL3MBTL1
SCHEMBL28850533 0.69 NQO2 (0.44) KMT2AALDH1A1HPGDBRD4CCNB2
SCHEMBL11436206 0.69 ALDH1A1 (0.56) KMT2AALDH1A1HPGDCCNB2CDK1
SCHEMBL8948085 0.68 TACR1 (0.52) KMT2ABRD4SMN1; SMN2L3MBTL1
SCHEMBL13568535 0.68 PCSK9 (0.47) KMT2AALDH1A1HPGDCCNB2CDK1
Hydrochloric Acid SCHEMBL16241844 0.68 NQO2 (0.43) KMT2AALDH1A1HPGDBRD4CCNB2
SCHEMBL27176107 0.68 ALDH1A1 (0.44) KMT2AALDH1A1HPGDBRD4SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5545645-A Heterocyclic derivatives in the treatment of ischaemia and related diseases SYNTEX PHARMACEUTICALS, LIMITED (GB) 1996-08-13 US disclosed
EP-0693062-A1 HETEROCYCLIC DERIVATIVES IN THE TREATMENT OF ISCHAEMIA AND RELATED DISEASES SYNTEX PHARMACEUTICALS LTD. (GB) 1996-01-24 EP disclosed
US-5428037-A Piperazine derivatives; calcium and sodium channel antagonists SYNTEX PHARMACEUTICALS, LTD. (GB) 1995-06-27 US disclosed
WO-1994024116-A1 HETEROCYCLIC DERIVATIVES IN THE TREATMENT OF ISCHAEMIA AND RELATED DISEASES SYNTEX PHARMACEUTICALS LIMITED (GB) 1994-10-27 WO disclosed